Bondues, France

Carole Belanger

This inventor holds 12 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignee: Genfit. Active years: 2018-2024.

USPTO Granted Patents = 12 

% Patents Active = 91.7

 

 

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Journey of Carole Belanger

Introduction

Carole Belanger, an accomplished inventor based in Bondues, France, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 12 patents, her work primarily revolves around developing advanced therapeutic compositions aimed at treating various diseases.

Latest Patents

Among her latest innovations are groundbreaking patents for pharmaceutical compositions for combination therapy. These inventions focus on a combination product and its application in therapy, as well as the integration of active ingredients to enhance treatment effectiveness. Her research emphasizes the importance of innovative solutions in addressing complex health challenges.

Career Highlights

Carole is currently a key member of the team at Genfit, a company dedicated to advancing medical research and improving patient outcomes. Her expertise in pharmacology and her dedication to innovation have positioned her at the forefront of pharmaceutical development.

Collaborations

Throughout her career, Carole has collaborated with notable professionals such as Robert Walczak and Raphael Darteil. These collaborations have not only enriched her research but have also contributed to a collaborative environment that fosters innovation within the pharmaceutical industry.

Conclusion

Carole Belanger's pioneering work and dedication to developing pharmaceutical compositions highlight her role as a leading inventor in her field. With each patent, she continues to pave the way for new therapeutic options, showcasing the impactful intersection of innovation and healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…